These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 330565)

  • 21. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 May; 63(5):954-65. PubMed ID: 312810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.
    Sagawa A; Abdou NI
    J Clin Invest; 1979 Mar; 63(3):536-9. PubMed ID: 311787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
    Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
    Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of stimulated neutrophils from patients with systemic lupus erythematosus in disturbed immunoreactivity, with special reference to increased oxygen intermediates generated by the neutrophils.
    Niwa Y; Sakane T; Shingu M; Yokoyama M
    J Clin Lab Immunol; 1984 May; 14(1):35-43. PubMed ID: 6086929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
    Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
    Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.
    Sasaki T; Shibata S; Hirabayashi Y; Sekiguchi Y; Yoshinaga K
    Clin Exp Immunol; 1989 Jul; 77(1):37-42. PubMed ID: 2788540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The dysfunction of human peripheral blood dendritic cells on concanavalin A-induced T cell responses in patients with systemic lupus erythematosus].
    Katagiri T
    Arerugi; 1992 Jun; 41(6):693-8. PubMed ID: 1444821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen.
    Gottlieb AB; Lahita RG; Chiorazzi N; Kunkel HG
    J Clin Invest; 1979 May; 63(5):885-92. PubMed ID: 312809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular immunity to nuclear antigens in systemic lupus erythematosus.
    Goldman JA; Litwin A; Adams LE; Krueger RC; Hess EV
    J Clin Invest; 1972 Oct; 51(10):2669-77. PubMed ID: 4560340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of purified human thymus-derived (T) cells by mitogens. II. Monocyte- macrophage potentiation of mitogen-induced DNA synthesis.
    Schmidtke JR; Hatfield S
    J Immunol; 1976 Feb; 116(2):357-62. PubMed ID: 1082454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phorbol myristate acetate (PMA) reverses inhibition of interleukin-2 production by T lymphocytes of patients with systemic lupus erythematosus.
    Sierakowski S; Kucharz EJ
    Med Interne; 1988; 26(1):67-73. PubMed ID: 3261032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
    Elliott LH; Brooks WH; Roszman TL
    J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of nonactivated and interferon-gamma activated monocytes in regulating normal and SLE patient B cell responses to TNP-Brucella abortus.
    Golding B; Tsokos GC; Fleisher T; Muchmore AV; Blaese RM
    J Immunol; 1986 Jul; 137(1):103-7. PubMed ID: 3086443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.